Malaria and Age Variably but Critically Control Hepcidin Throughout Childhood in Kenya

EBioMedicine

Volumn 2, Issue 10, 2015, Pages 1478-1486

  Atkinson, Sarah H ^a,b,c   Uyoga, Sophie M ^a   Armitage, Andrew E ^d,e   Khandwala, Shivani ^a,d   Mugyenyi, Cleopatra K ^a,f   Bejon, Philip ^a   Marsh, Kevin ^a   Beeson, James G ^f,h   Prentice, Andrew M ^g,i   Drakesmith, Hal ^d,e   Williams, Thomas N ^a,j  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e and University of Bristol   (United Kingdom)

^f BURNET INSTITUTE   (Australia)

^g MONASH UNIVERSITY   (Australia)

^h Medical Research Council (MRC) Unit The Gambia   (Gambia)

ⁱ MEDICAL RESEARCH COUNCIL   (United Kingdom)

^j IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

Africa; Age; Children; Hepcidin; Iron deficiency; Malaria

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; HEPCIDIN; TRANSFERRIN RECEPTOR; BIOLOGICAL MARKER; IRON; PARASITE ANTIGEN; PROTOZOON ANTIBODY;

AGE; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HUMAN; INFANT; IRON DEFICIENCY; KENYA; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALARIA; MALE; PARASITEMIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; ALPHA-THALASSEMIA; ANEMIA, IRON-DEFICIENCY; BLOOD; COMPLICATION; FOLLOW UP; HEALTH SURVEY; IMMUNOLOGY; KAPLAN MEIER METHOD; MALARIA, FALCIPARUM; METABOLISM; PARASITOLOGY; PROPORTIONAL HAZARDS MODEL; RISK; SENSITIVITY AND SPECIFICITY;

AGE FACTORS; ALPHA-THALASSEMIA; ANEMIA, IRON-DEFICIENCY; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BIOMARKERS; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEPCIDINS; HUMANS; INFANT; IRON; KAPLAN-MEIER ESTIMATE; KENYA; MALARIA; MALARIA, FALCIPARUM; MALE; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; RISK; SENSITIVITY AND SPECIFICITY;

EID: 84951908212     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2015.08.016     Document Type: Article

References (42)

1. Arezes J., Jung G., Gabayan V., Valore E., Ruchala P., Gulig P.A., Ganz T., Nemeth E., Bulut Y. Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus. Cell Host Microbe 2015, 17(1):47-57.
2. Armitage P., Berry G., Matthews J. Using STATA's robust cluster command as appropriate. Statistical Methods in Medical Research 2001, Oxford Blackwell Scientific Publications. 4th ed.
3. Armitage A.E., Pinches R., Eddowes L.A., Newbold C.I., Drakesmith H. Plasmodium falciparum infected erythrocytes induce hepcidin (HAMP) mRNA synthesis by peripheral blood mononuclear cells. Br. J. Haematol. 2009, 147(5):769-771.
4. Atkinson S.H., Armitage A.E., Khandwala S., Mwangi T.W., Uyoga S., Bejon P.A., Williams T.N., Prentice A.M., Drakesmith H. Combinatorial effects of malaria season, iron deficiency, and inflammation determine plasma hepcidin concentration in African children. Blood 2014, 123(21):3221-3229.
5. Ayoya M.A., Stoltzfus R.J., Spiekermann-Brouwer G.M., Nemeth E., Traore A.K., Ganz T., Garza C. Hepcidin and Plasmodium falciparum malaria in anemic school children in Mali. Bull. Soc. Pathol. Exot. 2009, 102(4):219-220.
6. Black M.M., Quigg A.M., Hurley K.M., Pepper M.R. Iron deficiency and iron-deficiency anemia in the first two years of life: strategies to prevent loss of developmental potential. Nutr. Rev. 2011, 69(Suppl. 1):S64-S70.
7. Burte F., Brown B.J., Orimadegun A.E., Ajetunmobi W.A., Afolabi N.K., Akinkunmi F., Kowobari O., Omokhodion S., Osinusi K., Akinbami F.O., Shokunbi W.A., Sodeinde O., Fernandez-Reyes D. Circulatory hepcidin is associated with the anti-inflammatory response but not with iron or anemic status in childhood malaria. Blood 2013, 121(15):3016-3022.
8. Cangemi G., Pistorio A., Miano M., Gattorno M., Acquila M., Bicocchi M.P., Gastaldi R., Riccardi F., Gatti C., Fioredda F., Calvillo M., Melioli G., Martini A., Dufour C. Diagnostic potential of hepcidin testing in pediatrics. Eur. J. Haematol. 2013, 90(4):323-330.
9. Casals-Pascual C., Huang H., Lakhal-Littleton S., Thezenas M.L., Kai O., Newton C.R., Roberts D.J. Hepcidin demonstrates a biphasic association with anemia in acute Plasmodium falciparum malaria. Haematologica 2012, 97(11):1695-1698.
10. Cercamondi C.I., Egli I.M., Ahouandjinou E., Dossa R., Zeder C., Salami L., Tjalsma H., Wiegerinck E., Tanno T., Hurrell R.F., Hounhouigan J., Zimmermann M.B. Afebrile Plasmodium falciparum parasitemia decreases absorption of fortification iron but does not affect systemic iron utilization: a double stable-isotope study in young Beninese women. Am. J. Clin. Nutr. 2010, 92(6):1385-1392.
11. Chong S.S., Boehm C.D., Higgs D.R., Cutting G.R. Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood 2000, 95(1):360-362.
12. de Mast Q., Nadjm B., Reyburn H., Kemna E.H., Amos B., Laarakkers C.M., Silalye S., Verhoef H., Sauerwein R.W., Swinkels D.W., van der Ven A.J. Assessment of urinary concentrations of hepcidin provides novel insight into disturbances in iron homeostasis during malarial infection. J. Infect. Dis. 2009, 199(2):253-262.
13. de Mast Q., Syafruddin D., Keijmel S., Riekerink T.O., Deky O., Asih P.B., Swinkels D.W., van der Ven A.J. Increased serum hepcidin and alterations in blood iron parameters associated with asymptomatic P. falciparum and P. vivax malaria. Haematologica 2010, 95(7):1068-1074.
14. Drakesmith H., Prentice A.M. Hepcidin and the iron-infection axis. Science 2012, 338(6108):768-772.
15. Elliott S.R., Fowkes F.J., Richards J.S., Reiling L., Drew D.R., Beeson J.G. Research priorities for the development and implementation of serological tools for malaria surveillance. F1000prime reports 2014, 6:100.
16. Ganz T. Iron in innate immunity: starve the invaders. Curr. Opin. Immunol. 2009, 21(1):63-67.
17. Ganz T. Hepcidin and iron regulation, 10years later. Blood 2011, 117(17):4425-4433.
18. Ganz T. Systemic iron homeostasis. Physiol. Rev. 2013, 93(4):1721-1741.
19. Glinz D., Hurrell R.F., Righetti A.A., Zeder C., Adiossan L.G., Tjalsma H., Utzinger J., Zimmermann M.B., N'Goran E.K., Wegmuller R. In Ivorian school-age children, infection with hookworm does not reduce dietary iron absorption or systemic iron utilization, whereas afebrile Plasmodium falciparum infection reduces iron absorption by half. Am. J. Clin. Nutr. 2015, 101(3):462-470.
20. Guida C., Altamura S., Klein F.A., Galy B., Boutros M., Ulmer A.J., Hentze M.W., Muckenthaler M.U. A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia. Blood 2015, 125(14):2265-2275.
21. Gwamaka M., Kurtis J.D., Sorensen B.E., Holte S., Morrison R., Mutabingwa T.K., Fried M., Duffy P.E. Iron deficiency protects against severe Plasmodium falciparum malaria and death in young children. Clin. Infect. Dis. 2012, 54(8):1137-1144.
22. Houngbedji C.A., N'Dri P.B., Hurlimann E., Yapi R.B., Silue K.D., Soro G., Koudou B.G., Acka C.A., Assi S.B., Vounatsou P., N'Goran E.K., Fantodji A., Utzinger J., Raso G. Disparities of Plasmodium falciparum infection, malaria-related morbidity and access to malaria prevention and treatment among school-aged children: a national cross-sectional survey in Cote d'Ivoire. Malar. J. 2015, 14(1):7.
23. Howard C.T., McKakpo U.S., Quakyi I.A., Bosompem K.M., Addison E.A., Sun K., Sullivan D., Semba R.D. Relationship of hepcidin with parasitemia and anemia among patients with uncomplicated Plasmodium falciparum malaria in Ghana. Am. J. Trop. Med. Hyg. 2007, 77(4):623-626.
24. Huang H., Constante M., Layoun A., Santos M.M. Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli. Blood 2009, 113(15):3593-3599.
25. Jaeggi T., Moretti D., Kvalsvig J., Holding P.A., Tjalsma H., Kortman G.A., Joosten I., Mwangi A., Zimmermann M.B. Iron status and systemic inflammation, but not gut inflammation, strongly predict gender-specific concentrations of serum hepcidin in infants in rural Kenya. PLoS One 2013, 8(2):e57513.
26. Jonker F.A., Calis J.C., Phiri K., Kraaijenhagen R.J., Brabin B.J., Faragher B., Wiegerinck E.T., Tjalsma H., Swinkels D.W., van Hensbroek M.B. Low hepcidin levels in severely anemic Malawian children with high incidence of infectious diseases and bone marrow iron deficiency. PLoS One 2013, 8(12):e78964.
27. Mugyenyi C.K., Elliott S.R., McCallum F.J., Anders R.F., Marsh K., Beeson J.G. Antibodies to polymorphic invasion-inhibitory and non-inhibitory epitopes of Plasmodium falciparum apical membrane antigen 1 in human malaria. PLoS One 2013, 8(7):e68304.
28. Mupfudze T.G., Stoltzfus R.J., Rukobo S., Moulton L.H., Humphrey J.H., Prendergast A.J., Team S.P. Hepcidin decreases over the first year of life in healthy African infants. Br. J. Haematol. 2014, 164(1):150-153.
29. Mwangi T.W., Ross A., Snow R.W., Marsh K. Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya. J. Infect. Dis. 2005, 191(11):1932-1939.
30. Nyakeriga A.M., Troye-Blomberg M., Dorfman J.R., Alexander N.D., Back R., Kortok M., Chemtai A.K., Marsh K., Williams T.N. Iron deficiency and malaria among children living on the coast of Kenya. J. Infect. Dis. 2004, 190(3):439-447.
31. Ondigo B.N., Hodges J.S., Ireland K.F., Magak N.G., Lanar D.E., Dutta S., Narum D.L., Park G.S., Ofulla A.V., John C.C. Estimation of recent and long-term malaria transmission in a population by antibody testing to multiple Plasmodium falciparum antigens. J. Infect. Dis. 2014, 210(7):1123-1132.
32. Portugal S., Carret C., Recker M., Armitage A.E., Goncalves L.A., Epiphanio S., Sullivan D., Roy C., Newbold C.I., Drakesmith H., Mota M.M. Host-mediated regulation of superinfection in malaria. Nat. Med. 2011, 17(6):732-737.
33. Prentice A.M., Doherty C.P., Abrams S.A., Cox S.E., Atkinson S.H., Verhoef H., Armitage A.E., Drakesmith H. Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children. Blood 2012, 119(8):1922-1928.
34. Punnonen K., Irjala K., Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997, 89(3):1052-1057.
35. Royston P., Altman D.G. Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling. Appl. Stat. 1994, 43:429-467.
36. Sdogou T., Tsentidis C., Gourgiotis D., Marmarinos A., Gkourogianni A., Papassotiriou I., Anastasiou T., Kossiva L. Immunoassay-based serum hepcidin reference range measurements in healthy children: differences among age groups. J. Clin. Lab. Anal. 2015, 29(1):10-14.
37. Stanisic D.I., Fowkes F.J., Koinari M., Javati S., Lin E., Kiniboro B., Richards J.S., Robinson L.J., Schofield L., Kazura J.W., King C.L., Zimmerman P., Felger I., Siba P.M., Mueller I., Beeson J.G. Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response. Infect. Immun. 2015, 83(2):646-660.
38. Vos T., Flaxman A.D., Naghavi M., Lozano R., Michaud C., Ezzati M., Shibuya K., Salomon J.A., Abdalla S., Aboyans V., Abraham J., Ackerman I., Aggarwal R., Ahn S.Y., Ali M.K., Alvarado M., Anderson H.R., Anderson L.M., Andrews K.G., Atkinson C., Baddour L.M., Bahalim A.N., Barker-Collo S., Barrero L.H., Bartels D.H., Basanez M.G., Baxter A., Bell M.L., Benjamin E.J., Bennett D., Bernabe E., Bhalla K., Bhandari B., Bikbov B., Bin Abdulhak A., Birbeck G., Black J.A., Blencowe H., Blore J.D., Blyth F., Bolliger I., Bonaventure A., Boufous S., Bourne R., Boussinesq M., Braithwaite T., Brayne C., Bridgett L., Brooker S., Brooks P., Brugha T.S., Bryan-Hancock C., Bucello C., Buchbinder R., Buckle G., Budke C.M., Burch M., Burney P., Burstein R., Calabria B., Campbell B., Canter C.E., Carabin H., Carapetis J., Carmona L., Cella C., Charlson F., Chen H., Cheng A.T., Chou D., Chugh S.S., Coffeng L.E., Colan S.D., Colquhoun S., Colson K.E., Condon J., Connor M.D., Cooper L.T., Corriere M., Cortinovis M., de Vaccaro K.C., Couser W., Cowie B.C., Criqui M.H., Cross M., Dabhadkar K.C., Dahiya M., Dahodwala N., Damsere-Derry J., Danaei G., Davis A., De Leo D., Degenhardt L., Dellavalle R., Delossantos A., Denenberg J., Derrett S., Des Jarlais D.C., Dharmaratne S.D., Dherani M., Diaz-Torne C., Dolk H., Dorsey E.R., Driscoll T., Duber H., Ebel B., Edmond K., Elbaz A., Ali S.E., Erskine H., Erwin P.J., Espindola P., Ewoigbokhan S.E., Farzadfar F., Feigin V., Felson D.T., Ferrari A., Ferri C.P., Fevre E.M., Finucane M.M., Flaxman S., Flood L., Foreman K., Forouzanfar M.H., Fowkes F.G., Franklin R., Fransen M., Freeman M.K., Gabbe B.J., Gabriel S.E., Gakidou E., Ganatra H.A., Garcia B., Gaspari F., Gillum R.F., Gmel G., Gosselin R., Grainger R., Groeger J., Guillemin F., Gunnell D., Gupta R., Haagsma J., Hagan H., Halasa Y.A., Hall W., Haring D., Haro J.M., Harrison J.E., Havmoeller R., Hay R.J., Higashi H., Hill C., Hoen B., Hoffman H., Hotez P.J., Hoy D., Huang J.J., Ibeanusi S.E., Jacobsen K.H., James S.L., Jarvis D., Jasrasaria R., Jayaraman S., Johns N., Jonas J.B., Karthikeyan G., Kassebaum N., Kawakami N., Keren A., Khoo J.P., King C.H., Knowlton L.M., Kobusingye O., Koranteng A., Krishnamurthi R., Lalloo R., Laslett L.L., Lathlean T., Leasher J.L., Lee Y.Y., Leigh J., Lim S.S., Limb E., Lin J.K., Lipnick M., Lipshultz S.E., Liu W., Loane M., Ohno S.L., Lyons R., Ma J., Mabweijano J., MacIntyre M.F., Malekzadeh R., Mallinger L., Manivannan S., Marcenes W., March L., Margolis D.J., Marks G.B., Marks R., Matsumori A., Matzopoulos R., Mayosi B.M., McAnulty J.H., McDermott M.M., McGill N., McGrath J., Medina-Mora M.E., Meltzer M., Mensah G.A., Merriman T.R., Meyer A.C., Miglioli V., Miller M., Miller T.R., Mitchell P.B., Mocumbi A.O., Moffitt T.E., Mokdad A.A., Monasta L., Montico M., Moradi-Lakeh M., Moran A., Morawska L., Mori R., Murdoch M.E., Mwaniki M.K., Naidoo K., Nair M.N., Naldi L., Narayan K.M., Nelson P.K., Nelson R.G., Nevitt M.C., Newton C.R., Nolte S., Norman P., Norman R., O'Donnell M., O'Hanlon S., Olives C., Omer S.B., Ortblad K., Osborne R., Ozgediz D., Page A., Pahari B., Pandian J.D., Rivero A.P., Patten S.B., Pearce N., Padilla R.P., Perez-Ruiz F., Perico N., Pesudovs K., Phillips D., Phillips M.R., Pierce K., Pion S., Polanczyk G.V., Polinder S., Pope C.A., Popova S., Porrini E., Pourmalek F., Prince M., Pullan R.L., Ramaiah K.D., Ranganathan D., Razavi H., Regan M., Rehm J.T., Rein D.B., Remuzzi G., Richardson K., Rivara F.P., Roberts T., Robinson C., De Leon F.R., Ronfani L., Room R., Rosenfeld L.C., Rushton L., Sacco R.L., Saha S., Sampson U., Sanchez-Riera L., Sanman E., Schwebel D.C., Scott J.G., Segui-Gomez M., Shahraz S., Shepard D.S., Shin H., Shivakoti R., Singh D., Singh G.M., Singh J.A., Singleton J., Sleet D.A., Sliwa K., Smith E., Smith J.L., Stapelberg N.J., Steer A., Steiner T., Stolk W.A., Stovner L.J., Sudfeld C., Syed S., Tamburlini G., Tavakkoli M., Taylor H.R., Taylor J.A., Taylor W.J., Thomas B., Thomson W.M., Thurston G.D., Tleyjeh I.M., Tonelli M., Towbin J.A., Truelsen T., Tsilimbaris M.K., Ubeda C., Undurraga E.A., van der Werf M.J., van Os J., Vavilala M.S., Venketasubramanian N., Wang M., Wang W., Watt K., Weatherall D.J., Weinstock M.A., Weintraub R., Weisskopf M.G., Weissman M.M., White R.A., Whiteford H., Wiersma S.T., Wilkinson J.D., Williams H.C., Williams S.R., Witt E., Wolfe F., Woolf A.D., Wulf S., Yeh P.H., Zaidi A.K., Zheng Z.J., Zonies D., Lopez A.D., Murray C.J., AlMazroa M.A., Memish Z.A. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859):2163-2196.
39. Wang H.Z., He Y.X., Yang C.J., Zhou W., Zou C.G. Hepcidin is regulated during blood-stage malaria and plays a protective role in malaria infection. J. Immunol. 2011, 187(12):6410-6416.
40. WHO World Malaria Report 2014, World Health Organization, Geneva, Switzerland.
41. WHO, CDC Assessing the iron status of populations: report of a joint World Health Organization/Centers for Disease Control and Prevention technical consultation on the assessment of iron status at the population level 2007, World Health Organization, Geneva, Switzerland.
42. WHO/UNICEF/UNU Iron deficiency anaemia: assessment, prevention, and control. A guide for Programme Managers 2001, World Health Organization, Geneva, Switzerland.